Biopheresis Technologies, Inc. Awarded Grant 'Biochance Plus-3' For The Development Of Its New Cancer Treatment Approach
11/10/2006 11:39:39 AM
More...
|
Biopheresis Technologies, Inc. Names Bernhard Ehmer Chief Executive Officer
5/9/2006 11:10:42 AM
More...
|
Biopheresis Technologies, Inc. Announces 6.5 Million Euro Financing From International Investors; Cancer Clinical Trial Planned For 2005
10/19/2005 5:10:20 PM
More...
|